| Mrs Kelli Kathleen Krause, MS CCC SLP | |
|
5606 S 147th St, Bellevue, NE 68137 | |
| (402) 201-4635 | |
| Not Available |
| Full Name | Mrs Kelli Kathleen Krause |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 5606 S 147th St, Bellevue, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922270776 | NPI | - | NPPES |
| 910 | Other | NE | SPEECH PATHOLOGY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 910 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Kelli Kathleen Krause, MS CCC SLP 5606 S 147th St, Omaha, NE 68137-2648 Ph: (402) 201-4635 | Mrs Kelli Kathleen Krause, MS CCC SLP 5606 S 147th St, Bellevue, NE 68137 Ph: (402) 201-4635 |
News Archive
The Research Council of Norway's Programme for Global Health and Vaccination Research (GLOBVAC) is co-funding testing of a new vaccine against Ebola that is drawing widespread international attention. The research programme has allocated NOK 20 million towards this work.
In contrast to the general belief that the airways of an infant are sterile until after birth, University of Alabama at Birmingham researchers and colleagues have found that the infant airway is already colonized with bacteria or bacterial DNA when a baby is born - and this is true for infants born as early as 24 weeks gestation.
Isis Pharmaceuticals, Inc. today provided an update on its ongoing open-label Phase 2 clinical studies of ISIS-SMN Rx in infants and children with spinal muscular atrophy at the 19th International World Muscle Society (WMS) Congress in Berlin, Germany.
Calcium antagonists such as nifedipine are used to relieve the symptoms of angina, but there have been doubts about their long-term safety. However, ACTION-A Coronary disease Trial Investigating Outcome with Nifedipine GITS-provides new information on the drug's long-term use. GITS (gastrointestinal therapeutic system) modifies the release of the drug to provide stable long-term concentrations of nifedipine in blood.
› Verified 2 days ago
Paula Pouliot, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3001 Spring Blvd, Bellevue, NE 68123 Phone: 402-293-5070 | |
Amy Schram, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12001 Timberridge Dr, Bellevue, NE 68133 Phone: 402-827-1850 | |
Ms. Malynda Carlene Mulvany, M.ED., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2202 Washington St, Bellevue, NE 68005 Phone: 402-293-4938 Fax: 402-293-4351 | |
Jillian Kahl, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2206 Longo Dr Ste 208, Bellevue, NE 68005 Phone: 712-308-8233 Fax: 888-975-0225 | |
Barbara Fisher, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13204 S 29th St, Bellevue, NE 68123 Phone: 402-293-4880 Fax: 402-293-5716 | |
Carol Eckstom, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12501 S 25th St, Bellevue, NE 68123 Phone: 402-293-4710 | |
Jessica Schram, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2726 Kennedy Blvd, Bellevue, NE 68123 Phone: 402-293-4760 |